Performance of QuantiFERON-TB Gold test compared to tuberculin skin test in detecting latent tuberculosis infection in HIV- positive individuals in Iran

被引:19
作者
Mardani, Masoud [1 ]
Tabarsi, Payam [2 ]
Mohammadtaheri, Zohre [2 ]
Chitsaz, Ehsan [2 ]
Farokhzad, Banafsheh [2 ]
Hadavand, Fatemeh [1 ]
Gachkar, Latif [1 ]
Nemati, Kambiz [1 ]
Masjedi, Mohammad R. [2 ]
机构
[1] Shahid Beheshti Med Univ, Iranian Infect Dis Res Ctr, Tehran, Iran
[2] Shahid Beheshti Med Univ, Mycobacteriol Res Ctr, NRITLD2, Tehran, Iran
关键词
Diagnosis; Iran; smoking; tobacco; tuberculosis; GAMMA RELEASE ASSAY; ANTIGENS; ADULTS;
D O I
10.4103/1817-1737.58959
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: There is limited data about the performance of QuantiFERON-TB Gold (QFT-G) test in detecting latent tuberculosis infection (LTBI) in our region. We intended to determine the performance of QFT-G compared to conventional tuberculin skin test (TST) in detecting LTBI in HIV-positive individuals in Iran. Methods: This study was conducted in a HIV clinic in Tehran, Iran in April 2007. A total of 50 consecutive HIV-positive patients, not currently affected with active tuberculosis (TB), were recruited; 43 (86) were male. The mean age was 38 7.2 years (21-53). All had history of Bacillus Calmette Guerin (BCG) vaccination. A TST with purified protein derivative (PPD) and whole-blood interferon-gamma release assay (IGRA) in reaction to ESAT-6 and CFP-10 antigens was performed and measured by enzyme-linked immuno-sorbent assay (ELISA). The agreement between TST and QFT-G results were analyzed using Kappa test. Results: A total of 36 (72) patients had negative and 14 (28) revealed positive TST. For QFT-G, 20 (40) tested positive, 19 (38) tested negative, and the results in 11 cases (22) were indeterminate. A total of 14 (28) patients had a CD4 count of 200. Of the 14, TST group, 12 had QFT-G , only one case TST/QFT-G-, and QFT-G was indeterminate in one TST positive case. Of the 36 patients with negative TST tests, 8 (22) had positive GFT-G and 10 (28) yielded indeterminate results. There was no association between a positive TST and receiving highly active anti-retroviral therapy (HAART) or absolute CD4 counts. Similarly, the association between QFT-G results and receiving HAART or CD4 counts was not significant (P = 0.06). Although TST results were not significantly different in patients with CD4 200 vs. CD4 > 200 (P = 0.295), association between QFT-G results and CD4 cutoff of 200 reached statistical significance (P = 0.027). Agreement Kappa coefficient between TST and QFT-G was 0.54 (Kappa = 0.54, 95 CI = 38.4-69.6, P < 0.001). Conclusion: Detecting LTBI in HIV-positive individuals showed moderate agreement between QFT-G and LTBI in our study. Interestingly, our findings revealed that nontuberculous mycobacteria and prior BCG vaccination have minimal influence on TST results in HIV patients in Iran.
引用
收藏
页码:43 / 46
页数:4
相关论文
共 19 条
  • [1] A comparative study of two different methods for the detection of latent tuberculosis in HIV-positive individuals in Chile
    Balcells, Maria Elvira
    Perez, Carlos M.
    Chanqueo, Leonardo
    Lasso, Martin
    Villanueva, Marcela
    Espinoza, Monica
    Villarroel, Luis
    Garcia, Patricia
    [J]. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2008, 12 (06) : 645 - 652
  • [2] TREATMENT OF TUBERCULOSIS AND TUBERCULOSIS INFECTION IN ADULTS AND CHILDREN
    BASS, JB
    FARER, LS
    HOPEWELL, PC
    OBRIEN, R
    JACOBS, RF
    RUBEN, F
    SNIDER, DE
    THORNTON, G
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1994, 149 (05) : 1359 - 1374
  • [3] Comparison of tuberculin skin test and new specific blood test in tuberculosis contacts
    Brock, L
    Weldingh, K
    Lillebaek, T
    Follmann, F
    Andersen, P
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2004, 170 (01) : 65 - 69
  • [4] Global epidemiology of tuberculosis
    Dye, C
    [J]. LANCET, 2006, 367 (9514) : 938 - 940
  • [5] Detection of latent tuberculosis among HIV-infected patients after initiation of highly active antiretroviral therapy
    Fisk, TL
    Hon, HM
    Lennox, JL
    von Reyn, CF
    Horsburgh, CR
    [J]. AIDS, 2003, 17 (07) : 1102 - 1104
  • [6] HARBOE M, 1981, AM REV RESPIR DIS, V124, P80
  • [7] THE TUBERCULIN SKIN-TEST
    HUEBNER, RE
    SCHEIN, MF
    BASS, JB
    [J]. CLINICAL INFECTIOUS DISEASES, 1993, 17 (06) : 968 - 975
  • [8] Jones S, 2007, INT J TUBERC LUNG D, V11, P1190
  • [9] Reaching the targets for tuberculosis control: the impact of HIV
    Laserson, K. F.
    Wells, C. D.
    [J]. BULLETIN OF THE WORLD HEALTH ORGANIZATION, 2007, 85 (05) : 377 - 381
  • [10] Laserson KF., 2007, Bull. World Health Organ, V85, P382